Literature DB >> 6198353

Stepwise amplified immunoperoxidase (PAP) staining. I. Cellular morphology in relation to membrane markers.

P M Lansdorp, T H van der Kwast, M de Boer, W P Zeijlemaker.   

Abstract

A novel procedure for the assay of monoclonal antibodies is described. The technique is based on a combination of three principles. Unlabeled (sheep) antiserum to mouse immunoglobulin (Ig) and complexes of peroxidase with mouse monoclonal antiperoxidase (monoclonal PAP complexes) are used as reagents in a variant of the unlabeled antibody enzyme (PAP) method, described by Sternberger. The amount of peroxidase eventually bound to a monoclonal antibody can be varied over a wide range by repetition of incubation cycles with anti-mouse Ig and monoclonal PAP complexes. During the assay, incubations and wash steps are performed by immersion of whole slides. The influence of repetitive incubation cycles with anti-mouse Ig and monoclonal PAP complexes on background staining and detection of monoclonal antibodies at low concentrations was quantitated in a model system. At a given primary antibody concentration, a linear relationship was found between peroxidase activity and the number of incubation cycles. Application of the technique to the detection of monoclonal antibodies bound to cell-surface antigens is described. Peripheral blood cells were labeled in suspension with monoclonal antibodies. Cytocentrifuge preparations of labeled cells were prepared, and such preparations were fixed before stepwise-amplified PAP staining. Cells showed intense specific staining. Morphological detail of stained and unstained cells is preserved, allowing morphological analysis of labeled cells and rapid analysis of monoclonal antibody specificity. Because the reagents used in the assay can be produced in large quantities with uniform quality, the technique can be readily automated. This, together with the possibility to increase the sensitivity of antibody detection in a controlled, stepwise fashion to levels that cannot be reached with "single-step" techniques, may further expand the applications of monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198353     DOI: 10.1177/32.2.6198353

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Improved avidin-biotin-peroxidase complex (ABC) staining.

Authors:  G Cattoretti; E Berti; R Schiró; L D'Amato; C Valeggio; F Rilke
Journal:  Histochem J       Date:  1988-02

2.  Increased sensitivity in peroxidase immunocytochemistry. A comparative study of a number of peroxidase visualization methods employing a model system.

Authors:  L Scopsi; L I Larsson
Journal:  Histochemistry       Date:  1986

3.  Monoclonal glucose-oxidase-anti-glucose-oxidase (GAG) immunosandwich assay for the detection of monoclonal antibodies on routine hematological smears.

Authors:  M Pfreundschuh; M Lehmann; T Steinmetz; H H Kirchner; V Diehl
Journal:  Blut       Date:  1988-03

4.  Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndrome.

Authors:  J Goudsmit; F Miedema; R J Wijngaarden-du Bois; M T Roos; P T Schellekens; R A Coutinho; J van der Noordaa; C J Melief
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo.

Authors:  A M Gown; H C Boyd; Y Chang; M Ferguson; B Reichler; D Tippens
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

6.  Monoclonal antibodies directed against rat liver epithelial cell lines selectively recognize bile duct epithelium in livers of adult rats.

Authors:  R Gebhardt; I Schäfer-Degenhart
Journal:  Cell Biol Toxicol       Date:  1988-12       Impact factor: 6.691

7.  HLA-DR antigen expression on the thyrocytes of Graves' disease patients.

Authors:  M S Lee; Y K Shong; B Y Cho; H K Lee; C S Koh; H K Min; M Lee; S K Oh; E S Whang; C Y Cha
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.